Literature DB >> 19541485

Hereditary motor and sensory neuropathy caused by a novel mutation in LITAF.

Wanda Maria Gerding1, Judith Koetting, Jörg Thomas Epplen, Clemens Neusch.   

Abstract

Hereditary motor-sensory neuropathy (HMSN) Type 1/CMT 1 is a disorder of the peripheral nervous system. The underlying genetic cause is heterogeneous, and mutations in LITAF (Lipopolysaccharide-induced TNF-alpha factor) represent a rare cause of CMT Type 1. In this report, a novel missense mutation is presented in the LITAF gene (c.430G>A p.V144M) in a German CMT family exhibiting typical electrophysiological features of a demyelinating neuropathy with conduction blocks and variable age at onset. Molecular genetic characterization of demyelinating HMSN should therefore include screening of the LITAF gene if typical signs of a non-homogenous demyelinating neuropathy combined with dominant familial occurrence are evident.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19541485     DOI: 10.1016/j.nmd.2009.05.006

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  18 in total

1.  Mutations associated with Charcot-Marie-Tooth disease cause SIMPLE protein mislocalization and degradation by the proteasome and aggresome-autophagy pathways.

Authors:  Samuel M Lee; James A Olzmann; Lih-Shen Chin; Lian Li
Journal:  J Cell Sci       Date:  2011-09-06       Impact factor: 5.285

2.  LITAF (Lipopolysaccharide-Induced Tumor Necrosis Factor) Regulates Cardiac L-Type Calcium Channels by Modulating NEDD (Neural Precursor Cell Expressed Developmentally Downregulated Protein) 4-1 Ubiquitin Ligase.

Authors:  Karni S Moshal; Karim Roder; Anatoli Y Kabakov; Andreas A Werdich; David Yi-Eng Chiang; Nilüfer N Turan; An Xie; Tae Yun Kim; Leroy L Cooper; Yichun Lu; Mingwang Zhong; Weiyan Li; Dmitry Terentyev; Bum-Rak Choi; Alain Karma; Calum A MacRae; Gideon Koren
Journal:  Circ Genom Precis Med       Date:  2019-08-28

3.  A novel LITAF/SIMPLE variant within a family with minimal demyelinating Charcot-Marie-Tooth disease.

Authors:  Marco Luigetti; Gian Maria Fabrizi; Federica Taioli; Alessandra Del Grande; Mauro Lo Monaco
Journal:  Neurol Sci       Date:  2014-05-21       Impact factor: 3.307

4.  Dysregulated Inflammatory Signaling upon Charcot-Marie-Tooth Type 1C Mutation of SIMPLE Protein.

Authors:  Wenjing Li; Hong Zhu; Xuelian Zhao; Deborah Brancho; Yuanxin Liang; Yiyu Zou; Craig Bennett; Chi-Wing Chow
Journal:  Mol Cell Biol       Date:  2015-07       Impact factor: 4.272

5.  Charcot-Marie-Tooth disease type 1C: Clinical and electrophysiological findings for the c.334G>a (p.Gly112Ser) Litaf/Simple mutation.

Authors:  Nivedita U Jerath; Michael E Shy
Journal:  Muscle Nerve       Date:  2017-04-29       Impact factor: 3.217

6.  Motor and sensory neuropathy due to myelin infolding and paranodal damage in a transgenic mouse model of Charcot-Marie-Tooth disease type 1C.

Authors:  Samuel M Lee; Di Sha; Anum A Mohammed; Seneshaw Asress; Jonathan D Glass; Lih-Shen Chin; Lian Li
Journal:  Hum Mol Genet       Date:  2013-01-28       Impact factor: 6.150

Review 7.  Charcot-Marie-Tooth disease and intracellular traffic.

Authors:  Cecilia Bucci; Oddmund Bakke; Cinzia Progida
Journal:  Prog Neurobiol       Date:  2012-03-22       Impact factor: 11.685

Review 8.  New evidence for secondary axonal degeneration in demyelinating neuropathies.

Authors:  Kathryn R Moss; Taylor S Bopp; Anna E Johnson; Ahmet Höke
Journal:  Neurosci Lett       Date:  2020-12-24       Impact factor: 3.046

9.  Mutation of SIMPLE in Charcot-Marie-Tooth 1C alters production of exosomes.

Authors:  Hong Zhu; Sara Guariglia; Raymond Y L Yu; Wenjing Li; Deborah Brancho; Hector Peinado; David Lyden; James Salzer; Craig Bennett; Chi-Wing Chow
Journal:  Mol Biol Cell       Date:  2013-04-10       Impact factor: 4.138

10.  SIMPLE: A new regulator of endosomal trafficking and signaling in health and disease.

Authors:  Lih-Shen Chin; Samuel M Lee; Lian Li
Journal:  Commun Integr Biol       Date:  2013-04-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.